CHENGDA PHARMA released its first-quarter performance, turning from profit to a loss of 1.4 million yuan
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, CHENGDA PHARMA released its first-quarter report for 2025, reporting an operating income of 76.3078 million yuan, a year-on-year decrease of 24.37%. The net loss attributable to shareholders of the listed company was 1.4 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 5.8541 million yuan. The basic loss per share was 0.0092 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments